Inhibition of the cloned delayed rectifier K+ channels, Kv1.5 and Kv3.1, by riluzole.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Neuroscience

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.NEUROSCIENCE.2005.03.041PMID 15964489
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Riluzole inhibits spontaneous Ca2+ signaling in neuroendocrine cells by activation of K+ channels and inhibition of Na+ channels

  2003cited by this paper
• Direct inhibition of the cloned Kv1.5 channel by AG-1478, a tyrosine kinase inhibitor.

  2002cited by this paper
• Modulation of recombinant and native neuronal SK channels by the neuroprotective drug riluzole.

  2002cited by this paper
• Neuroprotective agent riluzole dramatically slows inactivation of Kv1.4 potassium channels by a voltage-dependent oxidative mechanism.

  2001cited by this paper
• Interaction of the neuroprotective drug riluzole with GABA(A) and glycine receptor channels.

  2001cited by this paper
• Altered State Dependence of C-Type Inactivation in the Long and Short Forms of Human Kv1.5

  2001cited by this paper
• Effects of norfluoxetine, the major metabolite of fluoxetine, on the cloned neuronal potassium channel Kv3.1.

  2001cited by this paper
• Pharmacological modulation of SK3 channels.

  2001cited by this paper
• Casein Kinase 2 Determines the Voltage Dependence of the Kv3.1 Channel in Auditory Neurons and Transfected Cells

  2001cited by this paper
• Frequency‐independent blockade of cardiac Na+channels by riluzole: comparison with established anticonvulsants and class I anti‐arrhythmics

  2000cited by this paper
• Neuroreceptors and ion channels as the basis for drug action: past, present, and future.

  2000cited by this paper
• The neuroprotective agent riluzole activates the two P domain K(+) channels TREK-1 and TRAAK.

  2000cited by this paper
• The Neuroprotective Agent Riluzole Activates the Two P Domain K+ Channels TREK-1 and TRAAK

  2000cited by this paper
• Neuroprotective effects of riluzole: An electrophysiological and histological analysis in an in vitro model of ischemia

  1999cited by this paper
• Riluzole improves functional recovery after ischemia in the rat retina.

  1999cited by this paper
• Neuroprotective effects of riluzole in neurotrauma models: a review.

  1999cited by this paper
• Riluzole prevents ischemic spinal cord injury caused by aortic crossclamping.

  1999cited by this paper
• Characterization of Riluzole-Induced Stimulation of Large-Conductance Calcium-Activated Potassium Channels in Rat Pituitary GH3 Cells

  1999cited by this paper
• Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons.

  1998cited by this paper
• Single‐ and Multiple‐Dose Pharmacokinetics of Riluzole in White Subjects

  1997cited by this paper
• G-proteins are involved in riluzole inhibition of high voltage-activated calcium channels in rat dorsal root ganglion neurons.

  1997cited by this paper
• Differential action of riluzole on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels.

  1997cited by this paper
• Effects of the neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons.

  1997cited by this paper
• The pharmacology and mechanism of action of riluzole

  1996cited by this paper
• Riluzole Anesthesia: Use-Dependent Block of Presynaptic Glutamate Fibers

  1996cited by this paper
• Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat.

  1996cited by this paper
• Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis.

  1996cited by this paper
• Effect of riluzole on quinolinate-induced neuronal damage in rats: comparison with blockers of glutamatergic neurotransmission.

  1995cited by this paper
• Na+ channels as targets for neuroprotective drugs.

  1995cited by this paper
• Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole.

  1994cited by this paper
• Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action

  1994cited by this paper
• A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group.

  1994cited by this paper
• Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes.

  1993cited by this paper
• The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1.

  1993cited by this paper
• Expression of the mRNAs for the Kv3.1 potassium channel gene in the adult and developing rat brain.

  1992cited by this paper
• Anesthetic properties of riluzole (54274 RP), a new inhibitor of glutamate neurotransmission.

  1992cited by this paper
• Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia.

  1992cited by this paper
• Pertussis toxin pretreatment abolishes the inhibitory effect of riluzole and carbachol on D-[3H]aspartate release from cultured cerebellar granule cells.

  1992cited by this paper
• Drug distribution between blood and brain as a determinant of antipsychotic drug effects.

  1992cited by this paper
• Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre

  1991cited by this paper
• Molecular cloning and characterization of two voltage‐gated K+ channel cDNAs from human ventricle

  1991cited by this paper

• Distinct developmental dynamics of opposing persistent currents shape motoneuron firing during motor maturation of zebrafish

  2026cites this paper
• Ancillary subunits KChIP2c and DPP6 differentially modulate the inhibition of Kv4.2 channels by riluzole.

  2024cites this paper
• Roles of KCNA2 in Neurological Diseases: from Physiology to Pathology

  2024cites this paper
• Riluzole inhibits Kv4.2 channels acting on the closed and closed inactivated states.

  2021cites this paper
• Persistent sodium current blockers can suppress seizures caused by loss of low‐threshold D‐type potassium currents: Predictions from an in silico study of Kv1 channel disorders

  2020cites this paper
• The Effect of Glutamatergic Modulators on Extracellular Glutamate: How Does this Information Contribute to the Discovery of Novel Antidepressants?

  2019cites this paper
• Raloxifene inhibits cloned Kv4.3 channels in an estrogen receptor-independent manner

  2015cites this paper
• Inhibition of human Kv3.1 current expressed in Xenopus oocytes by the toxic venom fraction of Androctonus australis hector

  2014cites this paper
• Effects of haloperidol on Kv4.3 potassium channels.

  2014cites this paper
• The Sur1-Trpm4 Channel in Spinal Cord Injury.

  2013cites this paper
• Inhibition of Kv4.3 potassium channels by trazodone

  2013cites this paper
• Inhibition of human Kv3.1 current expressed in Xenopus oocytes by the toxic venom fraction of Androctonus australis hector

  2013cites this paper
• Progressive Hemorrhagic Necrosis - A Unique Pheno- type of Capillary Fragmentation

  2013cites this paper
• In silico docking reveals possible Riluzole binding sites on Nav1.6 sodium channel: implications for amyotrophic lateral sclerosis therapy.

  2012cites this paper
• Acoplamiento molecular in silico revela posibles sitios de unión entre Riluzol y el canal de sodio Nav1.6 implicaciones para la estrategia de diseño de fármacos en el síndrome de Esclerosis Lateral Amiotrofica

  2012cites this paper
• Deletion of TRAAK Potassium Channel Affects Brain Metabolism and Protects against Ischemia

  2012cites this paper
• Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury.

  2012cites this paper
• Persistent sodium current decreases transient gain in turtle motoneurons.

  2011cites this paper
• A Review of the Neural Mechanisms of Action and Clinical Efficiency of Riluzole in Treating Amyotrophic Lateral Sclerosis: What have we Learned in the Last Decade?

  2011influential citation
• Review of the Use of the Glutamate Antagonist Riluzole in Psychiatric Disorders and a Description of Recent Use in Childhood Obsessive-Compulsive Disorder

  2010cites this paper
• Differential Mechanisms Of Monoamine-Induced Oscillations In The Lobster Pyloric Pacemaker Neuron

  2010cites this paper
• Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a New Activator of KCa2 and KCa3.1 Potassium Channels, Potentiates the Endothelium-Derived Hyperpolarizing Factor Response and Lowers Blood Pressure

  2009cites this paper
• Predominant Functional Expression of Kv1.3 by Activated Microglia of the Hippocampus after Status epilepticus

  2009cites this paper
• SKA-31, A New Activator of KCa2 And KCa3.1 Potassium Channels, Potentiates the EDHF Response and Lowers Blood Pressure

  2009cites this paper
• Major depression: emerging therapeutics.

  2008cites this paper
• Control of neuronal persistent activity by voltage-dependent dendritic properties.

  2008cites this paper
• Riluzole in the Treatment of Mood and Anxiety Disorders

  2008cites this paper
• Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro

  2008cites this paper
• Persistent Sodium Currents Participate in Fictive Locomotion Generation in Neonatal Mouse Spinal Cord

  2007cites this paper
• Contribution of persistent sodium current to locomotor pattern generation in neonatal rats.

  2007cites this paper
• Opposing inward and outward conductances regulate rebound discharges in olfactory mitral cells.

  2007cites this paper
• Interaction of Riluzole with the Closed Inactivated State of Kv4.3 Channels

  2006cites this paper
• Kv1.5 is a major component underlying the A-type potassium current in retinal arteriolar smooth muscle

  2006cites this paper